Medical Campus aerial
Hepatology Program

The Hepatology Program at Michigan Medicine is one of the largest and most prestigious programs in the world. Our team has excelled in research, education, and in providing compassionate care since 1954.
For More Information
Program Overview

Led by Dr. Neehar Parikh and Dr. Elliot Tapper, the Hepatology Program includes 18 faculty members and four advanced practice providers with world-leading expertise in a wide variety of liver diseases

Learn more about our program's leadership and history

Leading with excellence: The Division of Gastroenterology and Hepatology at the University of Michigan is the largest in the United States, with a large, dedicated team that takes a three-tiered approach to delivering care for liver disease.
About

Learn more about our program's history, our team members and our mission for providing state-of-the-art liver care.

Research

With a broad research portfolio, our program’s investigations span scientific, clinical and health services research.

Education

Our team is committed to the training of fellows in the GI Fellowship Program and Transplant Hepatology Fellowship Program.

Patient Care

Find clinic information, specialty clinics, procedure information and more.

Lectures & CME

During the year, we provide a variety of hepatology educational lectures and CME courses to U-M faculty as well as external health care providers.

See Opportunities
Featured News & Stories See all news syringes three in a row with one with a shot going into it on a light teal background
Health Lab
TNF inhibitors prevent complications in kids with Crohn’s disease, recommended as first-line therapies
Early treatment of pediatric Crohn’s disease with anti-tumor necrosis factor medications can substantially reduce the risk of perianal fistulas in Crohn’s disease. Michigan Medicine researchers confirmed this finding using prospective data. 
 man in pink shirt close up with hand on stomach
Health Lab
Potential culprit identified in lingering Crohn’s disease symptoms
A study from University of Michigan researchers may explain why some patients with Crohn’s disease continue to experience symptoms, even in the absence of inflammation.
 Clarivate’s Highly Cited Researchers 2024
Department News
Internal Medicine Faculty Named to Clarivate’s Highly Cited Researchers List
Nine faculty members from the Department of Internal Medicine named to Clarivate’s Highly Cited Researchers 2024 List.
 close up of sensor
Health Lab
Stent sensor can warn of blockages in the bile duct
Currently, medical providers monitor biliary stent blockages through blood tests, meaning the problem must be significant enough for the body to notice. A sensor within the stent could enable doctors to recognize that bacterial sludge is accumulating and intervene before the patient begins to fall ill.
 27th Annual Liver Disease Wrap-Up
Department News
27th Annual Liver Disease Wrap-Up
Join us for the 27th Annual Liver Disease Wrap-Up conference taking place on Saturday, December 7, 2024
 machine beige black
Health Lab
Histotripsy liver tumor trial successful, early clinical adoption recommended
The #HOPE4LIVER trials, testing the safety efficacy of histotripsy as a treatment for primary and metastatic liver tumors, met its goals for technical success and safety. An expert explains more about it in this article.
Stay Connected With Us